Titan Pharmaceuticals
TTNP
#10769
Rank
S$7.95 M
Marketcap
S$5.98
Share price
-3.76%
Change (1 day)
18.32%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -S$3.69 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$6.11 Million, an increase over its 2023 earnings that were of -S$7.23 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$3.69 Million-39.59%
2024 -S$6.11 Million-15.5%
2023 -S$7.23 Million-45.43%
2022 -S$13.24 Million16.29%
2021 -S$11.38 Million-907.36%
2020 S$1.4 M-106.6%
2019 -S$21.35 Million82.4%
2018 -S$11.7 Million-36.93%
2017 -S$18.56 Million-378.62%
2016 S$6.65 M-145.53%
2015 -S$14.63 Million369.37%
2014 -S$3.12 Million-125.9%
2013 S$12.03 M-177.74%
2012 -S$15.48 Million13.59%
2011 -S$13.63 Million74.37%
2010 -S$7.82 Million3.61%
2009 -S$7.55 Million
2007 -S$23.91 Million12.08%
2006 -S$21.33 Million-28.65%
2005 -S$29.89 Million-10.03%
2004 -S$33.23 Million-6.08%
2003 -S$35.38 Million-14.76%
2002 -S$41.5 Million32.52%
2001 -S$31.32 Million27.55%
2000 -S$24.56 Million62.5%
1999 -S$15.11 Million4.04%
1998 -S$14.53 Million49.33%
1997 -S$9.73 Million-27.88%
1996 -S$13.49 Million13.04%
1995 -S$11.93 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.68 B-926,267.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$20.46 B-562,809.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-S$0.16 Billion 4,217.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
S$0.10 B-3,090.94%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-S$15.57 Million 327.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.38 Billion 10,144.78%๐Ÿ‡บ๐Ÿ‡ธ USA